Literature DB >> 33450584

A near-infrared light-responsive extracellular vesicle as a "Trojan horse" for tumor deep penetration and imaging-guided therapy.

Zeng Xu1, Huabei Huang1, Xiang Xiong1, Xiaoqing Wei1, Xing Guo1, Jingya Zhao2, Shaobing Zhou3.   

Abstract

How to make the nanoparticles evade immune surveillance and deeply penetrate the tumor tissues is of great importance to maximize the therapeutic efficacy of nanomedicines. Here, a near-infrared (NIR) light-responsive extracellular vesicle as a nanoplatform is developed to realize long circulation in blood, deep penetration in tumor tissues and rapid body elimination after the treatment. Like a "Trojan horse", the nanoplatform is obtained by hiding the anti-tumor soldiers (DOX and 4.2 nm Ag2S quantum dots (QDs)) into the macrophage cell-secreted vesicle through electroporation. The natural composition and tumor targeting activity of the extracellular vesicles enable the nanoplatform to achieve a high accumulation in tumor and the in vivo biodistribution can be monitored by NIR fluorescence imaging of the Ag2S QDs. After the nanomedicines accumulate at the tumor sites, the soldiers will be released from the "Trojan horse" by utilizing the NIR photothermal effect of the Ag2S QDs. The released ultrasmall QDs and DOX can penetrate the whole tumor with a diameter of about 9 mm and effectively kill the tumor cells. Moreover, the inorganic QDs can be rapidly excreted from the body through renal clearance after the treatment to avoid the potential toxicity.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Extracellular vesicles; Fluorescence imaging; Near-infrared; Quantum dots; Trojan horse; Tumor penetration

Mesh:

Year:  2021        PMID: 33450584     DOI: 10.1016/j.biomaterials.2020.120647

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy.

Authors:  Jingya Zhao; Huabei Huang; Jinyan Zhao; Xiang Xiong; Sibo Zheng; Xiaoqing Wei; Shaobing Zhou
Journal:  Acta Pharm Sin B       Date:  2021-10-26       Impact factor: 14.903

2.  pH-responsive hybrid platelet membrane-coated nanobomb with deep tumor penetration ability and enhanced cancer thermal/chemodynamic therapy.

Authors:  Huang Yang; Yuan Ding; Zongrui Tong; Xiaohui Qian; Hao Xu; Fenghao Lin; Guoping Sheng; Liangjie Hong; Weilin Wang; Zhengwei Mao
Journal:  Theranostics       Date:  2022-05-16       Impact factor: 11.600

3.  A simple, universal and multifunctional template agent for personalized treatment of bone tumors.

Authors:  Wei-Bo Liu; Su-He Dong; Wen-Hao Hu; Meng Gao; Teng Li; Quan-Bo Ji; Xiao-Qing Yang; Deng-Bin Qi; Zhen Zhang; Ze-Long Song; Yu-Jie Liu; Xue-Song Zhang
Journal:  Bioact Mater       Date:  2021-10-26

4.  Emodin-Conjugated PEGylation of Fe3O4 Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer.

Authors:  Shuai Ren; Lina Song; Ying Tian; Li Zhu; Kai Guo; Huifeng Zhang; Zhongqiu Wang
Journal:  Int J Nanomedicine       Date:  2021-11-06

5.  Multipotent Poly(Tertiary Amine-Oxide) Micelles for Efficient Cancer Drug Delivery.

Authors:  Jiajia Xiang; Yihuai Shen; Yifan Zhang; Xin Liu; Quan Zhou; Zhuxian Zhou; Jianbin Tang; Shiqun Shao; Youqing Shen
Journal:  Adv Sci (Weinh)       Date:  2022-02-20       Impact factor: 17.521

Review 6.  Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies.

Authors:  Hailong Tian; Tingting Zhang; Siyuan Qin; Zhao Huang; Li Zhou; Jiayan Shi; Edouard C Nice; Na Xie; Canhua Huang; Zhisen Shen
Journal:  J Hematol Oncol       Date:  2022-09-12       Impact factor: 23.168

7.  M1 Macrophage-Derived Nanovesicles Repolarize M2 Macrophages for Inhibiting the Development of Endometriosis.

Authors:  Qiuju Li; Ming Yuan; Xue Jiao; Yufei Huang; Jing Li; Dong Li; Miaomiao Ji; Guoyun Wang
Journal:  Front Immunol       Date:  2021-07-20       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.